1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Neuromodulation Market, by Technology
6.1. Introduction
6.2. Deep Brain Stimulation
6.3. Gastric Stimulation
6.4. Sacral Nerve Stimulation
6.5. Spinal Cord Stimulation
6.6. Vagus Nerve Stimulation

7. Neuromodulation Market, by Application
7.1. Introduction
7.2. Chronic Pain
7.3. Dystonia
7.4. Essential Tremor
7.5. Gastroparesis
7.6. Obsessive Compulsive Disorder
7.7. Parkinson's Disease
7.8. Refractory Epilepsy
7.9. Treatment Resistant Depression
7.10. Urinary Fecal Incontinence

8. California Neuromodulation Market

9. Florida Neuromodulation Market

10. Illinois Neuromodulation Market

11. New York Neuromodulation Market

12. Ohio Neuromodulation Market

13. Pennsylvania Neuromodulation Market

14. Texas Neuromodulation Market

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. Advanced Bionics
16.2. Boston Scientific Corporation
16.3. Cochlear Ltd.
16.4. Cyberonics
16.5. Greatbatch
16.6. Medtronic Plc
16.7. Neuronetics, Inc.
16.8. Nevro Corporation
16.9. Sonova Group
16.10. St. Jude Medical

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES NEUROMODULATION MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES NEUROMODULATION MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 6. UNITED STATES NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES NEUROMODULATION MARKET SIZE, BY GASTRIC STIMULATION, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES NEUROMODULATION MARKET SIZE, BY GASTRIC STIMULATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 14. UNITED STATES NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 16. UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 17. UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2027
FIGURE 19. UNITED STATES NEUROMODULATION MARKET SIZE, BY CHRONIC PAIN, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES NEUROMODULATION MARKET SIZE, BY CHRONIC PAIN, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES NEUROMODULATION MARKET SIZE, BY DYSTONIA, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES NEUROMODULATION MARKET SIZE, BY DYSTONIA, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES NEUROMODULATION MARKET SIZE, BY ESSENTIAL TREMOR, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES NEUROMODULATION MARKET SIZE, BY ESSENTIAL TREMOR, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES NEUROMODULATION MARKET SIZE, BY GASTROPARESIS, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES NEUROMODULATION MARKET SIZE, BY GASTROPARESIS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES NEUROMODULATION MARKET SIZE, BY OBSESSIVE COMPULSIVE DISORDER, 2018-2027 (USD MILLION)
FIGURE 28. UNITED STATES NEUROMODULATION MARKET SIZE, BY OBSESSIVE COMPULSIVE DISORDER, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES NEUROMODULATION MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2027 (USD MILLION)
FIGURE 30. UNITED STATES NEUROMODULATION MARKET SIZE, BY PARKINSON'S DISEASE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES NEUROMODULATION MARKET SIZE, BY REFRACTORY EPILEPSY, 2018-2027 (USD MILLION)
FIGURE 32. UNITED STATES NEUROMODULATION MARKET SIZE, BY REFRACTORY EPILEPSY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 33. UNITED STATES NEUROMODULATION MARKET SIZE, BY TREATMENT RESISTANT DEPRESSION, 2018-2027 (USD MILLION)
FIGURE 34. UNITED STATES NEUROMODULATION MARKET SIZE, BY TREATMENT RESISTANT DEPRESSION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 35. UNITED STATES NEUROMODULATION MARKET SIZE, BY URINARY FECAL INCONTINENCE, 2018-2027 (USD MILLION)
FIGURE 36. UNITED STATES NEUROMODULATION MARKET SIZE, BY URINARY FECAL INCONTINENCE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 37. UNITED STATES NEUROMODULATION MARKET: FPNV POSITIONING MATRIX
FIGURE 38. UNITED STATES NEUROMODULATION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 39. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES NEUROMODULATION MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES NEUROMODULATION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES NEUROMODULATION MARKET SIZE, BY GASTRIC STIMULATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES NEUROMODULATION MARKET SIZE, BY CHRONIC PAIN, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES NEUROMODULATION MARKET SIZE, BY DYSTONIA, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES NEUROMODULATION MARKET SIZE, BY ESSENTIAL TREMOR, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES NEUROMODULATION MARKET SIZE, BY GASTROPARESIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES NEUROMODULATION MARKET SIZE, BY OBSESSIVE COMPULSIVE DISORDER, BY STATE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES NEUROMODULATION MARKET SIZE, BY PARKINSON'S DISEASE, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES NEUROMODULATION MARKET SIZE, BY REFRACTORY EPILEPSY, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES NEUROMODULATION MARKET SIZE, BY TREATMENT RESISTANT DEPRESSION, BY STATE, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES NEUROMODULATION MARKET SIZE, BY URINARY FECAL INCONTINENCE, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES NEUROMODULATION MARKET: SCORES
TABLE 20. UNITED STATES NEUROMODULATION MARKET: BUSINESS STRATEGY
TABLE 21. UNITED STATES NEUROMODULATION MARKET: PRODUCT SATISFACTION
TABLE 22. UNITED STATES NEUROMODULATION MARKET: RANKING
TABLE 23. UNITED STATES NEUROMODULATION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 24. UNITED STATES NEUROMODULATION MARKET: MERGER & ACQUISITION
TABLE 25. UNITED STATES NEUROMODULATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 26. UNITED STATES NEUROMODULATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 27. UNITED STATES NEUROMODULATION MARKET: INVESTMENT & FUNDING
TABLE 28. UNITED STATES NEUROMODULATION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 29. UNITED STATES NEUROMODULATION MARKET: LICENSE & PRICING

Companies Mentioned

Advanced Bionics
Boston Scientific Corporation
Cochlear Ltd.
Cyberonics
Greatbatch
Medtronic Plc
Neuronetics, Inc.
Nevro Corporation
Sonova Group
St. Jude Medical